Speakers and Moderators


Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Tumori Fondazione Pascale, Naples, Italy

Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon

Pier Luigi Canonico
Department of Scienze del Farmaco, University of Piemonte Orientale, Novara, Italy

Ana Carizzosa Anderson
Assistant Professor at Kuchroo Laboratory, Center for Neurologic Disease Brigham and Women's Hospital
Harvard Medical School, Boston, Massachusetts

Lotfi Chouchane
Assistant Dean for Basic Science, Professor of Genetic Medicine, Professor of Microbiology & Immunology, Weill Cornell Medical College, Qatar

Gennaro Ciliberto
Scientific Director of the National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Alistair Cochran
Distinguished Professor of Pathology and Laboratory Medicine, UCLA, California

Francesco De Lorenzo*
President of Italian Federation of Volunteer-based Cancer Organizations, FAVO

Sabino De Placido*
Professor of Medical Oncology, University of Naples, Italy

Alexander Eggermont
Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, France

Mark Faries
Department of Surgical Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California

Soldano Ferrone
University of Pittsburgh, Department of Pathology and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Thomas F. Gajewski
Department of Pathology and Department of Medicine, Section of Hematology/Oncology, Chicago, Illinois

Jerome Galon
Research Director at INSERM (National Institute of Health and Medical Research), Paris, France

Clause Garbe
University Professor of Dermatology, Head, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany

Jeffrey E. Gershenwald Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Ruth Halaban
Director, Yale SPORE in Skin Cancer, Yale University School of Medicine, Department of Dermatology, New Haven, Connecticut

F. Stephen Hodi
Dana-Farber Cancer Institute, Boston, Massachusetts

Richard Kefford
Professor of Medicine and Director of the Westmead Institute for Cancer Research and Consultant Medical Oncologist to the Sydney Melanoma Unit and the NSW Breast Cancer Institute, Sydney, Australia

John Kirkwood
Usher Professor of Medicine, Dermatology, and Translational Science University of Pittsburgh School of Medicine Director, Melanoma and Skin Cancer Program University of Pittsburgh Cancer Institute

James Larkin
Department of Medicine, The Royal Marsden Hospital, London, UK

Sancy Leachman
Professor and Chair, Department of Dermatology, Oregon Health & Sciences University

Michele Maio
U.O.C. Immunoterapia Oncologica Azienda Ospedaliera Universitaria Senese, Siena, Italy

Alberto Mantovani
Scientific Director of Istituto Clinico Humanitas, Milan, Italy
Richard Marais
Director, Paterson Institute for Cancer Research, Manchester, United Kingdom

Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar

Giuseppe Masucci
Professor, Department of Oncology-Pathology, and KcRN, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden

Ignacio Melero
Professor of Immunology and Consultant, CIMA, CUN and Medical School, University of Navarra, Pamplona, Spain

Nicola Mozzillo
Director of the Department Melanoma and Soft Tissues, Istituto Tumori - Fondazione G. Pascale, Naples, Italy

Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy

Luca Pani
General Director, Italian Medicines Agency - AIFA

Carmine Pinto
National Secretary of Associazione Italiana di Oncologia Medica, AIOM

Igor Puzanov
Associate Professor of Medicine, Clinical Director, Renal Cancer/Melanoma, Vanderbilt University, Nashville, Tennessee

Antoni Ribas
Professor of Medicine, Surgery, and Molecular and Medical Pharmacology at the University of California Los Angeles, California

Yvonne Saenger
Departments of Dermatology, Mount Sinai School of Medicine, New York

Bastian Schilling
Department of Dermatology, University Hospital Essen, Essen, Germany

Barbara Seliger
Institute of Medical Immunology, Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany

David Stroncek
Chief, Cell Processing Section, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, Maryland

Ryan Sullivan
Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Alessandro Testori
Melanoma and muscle-cutaneous sarcomas Division, Istituto Europeo di Oncologia, Milan, Italy

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland

Fernando Vidal-Vanaclocha
Professor of Cell Biology and Human Histology, Vice Dean for Research and International Affairs and Scientific Director of the Institute of Applied Molecular Medicine (IMMA) at the CEU-San Pablo University School of Medicine, Madrid, Spain

Ena Wang
Acting Section Head of Infectious Disease and Immunogenetics Section (IDIS); Director of Molecular Science, Department of Transfusion Medicine, CC; Associated director of Center for Human Immunology, NIH, Maryland

*invited speaker




For information please contact info@melanomabridge.org